title: Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival.
authors.forename: G E
authors.initials: GE
authors.lastname: Tjønnfjord
authors.forename: T
authors.initials: T
authors.lastname: Gedde-Dahl
authors.forename: D
authors.initials: D
authors.lastname: Heldal
authors.forename: L
authors.initials: L
authors.lastname: Brinch
mesh_terms: D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D015331:Cohort Studies; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016130:Immunophenotyping; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000401:mortality* / Q000628:therapy*; D012008:Recurrence; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents